Kratos Mobile Laboratory Product Supporting COVID-19 Response Efforts
Kratos Defense & Security Solutions (NASDAQ: KTOS) has deployed its Mobile Laboratory Product as part of the National Guard's COVID-19 response. This initiative, developed by the Kratos C5ISR Division, supports the Department of Defense’s Analytical Laboratory System program. The mobile labs are designed for detecting CBRNE materials and have been adapted for clinical specimen testing during the pandemic. Since the initial contract in 2015, Kratos has received additional orders for a total of 67 units, enhancing the nation’s pandemic response capabilities.
- Deployment of Mobile Laboratory Product supports COVID-19 testing efforts.
- Total of 67 ALS units ordered, indicating strong demand.
- Enhanced laboratory capacity to assist in pandemic response.
- None.
SAN DIEGO, May 14, 2020 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that its Mobile Laboratory Product, developed in part by the Kratos Command, Control, Communications, Computing, Combat & Intelligence, Surveillance and Reconnaissance (C5ISR) Division for the Department of Defense’s Analytical Laboratory System, Modified Work Order (ALS MWO) program, has been deployed as part of the National Guard’s efforts to combat COVID-19.
The ALS program, run through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), provides a common, mobile laboratory capability to DoD field analytic units across multiple domain spaces. The system provides on-site capability to detect and/or identify a wide range of CBRNE materials in environmental samples. These mobile units have been adapted to conduct clinical specimen testing in support of COVID-19 response efforts and are being deployed to the epicenters of the pandemic within the United States to provide additional laboratory capacity and capabilities to support increased testing activities.
Tom Mills, President of Kratos C5ISR Division, said, "Kratos C5ISR is a key collaborator on the team of suppliers that provides the ALS mobile laboratory system to the Warfighter. This critical platform was specifically designed and put in place to increase our nation’s readiness against a number of chemical and biological threats. We are proud to deliver a product in support of the fight against COVID-19.”
Eric DeMarco, President & CEO of Kratos, said, “Kratos prides itself on our affordable, leading-edge technologies that enhance the resiliency of our nation’s security. As America confronts this new type of enemy, we are proud to have our product on the front lines of the pandemic to bolster essential testing capabilities and assist our health care heroes.”
In August 2015, Kratos was awarded an initial contract to design and manufacture four (4) prototype, next generation ALS shelter systems. These units featured several design enhancements over existing systems, addressed obsolescence issues and optimized the Warfighter’s ability to analyze data. Since initial prototype production, Kratos C5ISR has been awarded three (3) additional orders for a total of 67 ALS units, with production ongoing as of May 2020.
Kratos C5ISR Division is a leading provider of products, hardware, systems and subsystems in support of unmanned aerial vehicle, high powered directed energy, missiles, missile defense, radar, surface combatant and other combat and weapon systems and programs.
About Kratos Defense & Security Solutions, Inc.
Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms and systems for United States National Security related customers, allies and commercial enterprises. Kratos is changing the way breakthrough technology for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research and streamlined development processes. Kratos specializes in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training and combat systems, and next-generation turbojet and turbo-fan engine development. For more information, go to www.KratosDefense.com.
Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 29, 2019, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Kratos.
Press Contact:
Yolanda White
858-812-7302 Direct
Investor Information:
877-934-4687
investor@kratosdefense.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2520dada-5409-41c3-b4ce-233bddc63a93
FAQ
What is the significance of Kratos Defense's Mobile Laboratory Product?
How many ALS units has Kratos received orders for?
Who developed the Mobile Laboratory Product for the Department of Defense?
When was the initial contract for the ALS shelter systems awarded to Kratos?
What role does the JPEO-CBRND play in the deployment of these labs?
